Niamh C. Williams

Niamh C. Williams

Auto-generated profile, based on publicly available information

Niamh C. Williams

School of Medicine, Trinity Biomedical Sciences Institute, and

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
ASAnna Santarsiero
Anna Santarsiero
PCPaolo Convertini
Paolo Convertini
STSimona Todisco
Simona Todisco
Ciro Leonardo PierriCiro Leonardo Pierri
Ciro Leonardo Pierri
AGAnna De Grassi
Anna De Grassi
VIVittoria Infantino
Vittoria Infantino
Macrophage stimulation by pathogen-associated molecular patterns (PAMPs) like lipopolysaccharide (LPS) or lipoteichoic acid (LTA) drives a proinflammatory phenotype and induces a metabolic reprogramming to sustain the cell’s function. Nevertheless, the relationship between metabolic shifts and gene expression remains poorly explored. In this context, the metabolic enzyme ATP citrate lyase (ACLY), the producer of citrate-derived acetyl-coenzyme A (CoA), plays a critical role in supporting a proinflammatory response. Through immunocytochemistry and cytosol–nucleus fractionation, we found a short-term ACLY nuclear translocation. Protein immunoprecipitation unveiled the role of nuclear ACLY in NF-κB acetylation and in turn its full activation in human PBMC-derived macrophages. Notably, sepsis in the early hyperinflammatory phase triggers ACLY-mediated NF-κB acetylation. The ACLY/NF-κB axis increases the expression levels of proinflammatory genes, including SLC25A1—which encodes the mitochondrial citrate carrier—and ACLY, thus promoting the existence of a proinflammatory loop involving SLC25A1 and ACLY genes.

22 August 2023 in JCI Insight
Verified
Journal Article
Open access
PDF file
LFLi-Chao Fan
Li-Chao Fan
KMKeith McConn
Keith McConn
MPMaria Plataki
Maria Plataki
SKSarah Kenny
Sarah Kenny
NWNiamh C. Williams
Niamh C. Williams
SCSuzanne M. Cloonan
Suzanne M. Cloonan
Alveolar epithelial type II (AEC2) cells strictly regulate lipid metabolism to maintain surfactant synthesis. Loss of AEC2 cell function and surfactant production are implicated in the pathogenesis of the smoking-related lung disease chronic obstructive pulmonary disease (COPD). Whether smoking alters lipid synthesis in AEC2 cells and whether altering lipid metabolism in AEC2 cells contributes to COPD development are unclear. In this study, high-throughput lipidomic analysis revealed increased lipid biosynthesis in AEC2 cells isolated from mice chronically exposed to cigarette smoke (CS). Mice with a targeted deletion of the de novo lipogenesis enzyme, fatty acid synthase (FASN), in AEC2 cells ( Fasn iΔAEC2 ) exposed to CS exhibited higher bronchoalveolar lavage fluid (BALF) neutrophils, higher BALF protein, and more severe airspace enlargement. Fasn iΔAEC2 mice exposed to CS had lower levels of key surfactant phospholipids but higher levels of BALF ether phospholipids, sphingomyelins, and polyunsaturated fatty acid–containing phospholipids, as well as increased BALF surface tension. Fasn iΔAEC2 mice exposed to CS also had higher levels of protective ferroptosis markers in the lung. These data suggest that AEC2 cell FASN modulates the response of the lung to smoke by regulating the composition of the surfactant phospholipidome.

1 February 2020 in Trends in Immunology
Verified
Journal Article
Closed access
NWNiamh C. Williams
Niamh C. Williams
Luke O'NeillLuke O'Neill
Luke O'Neill